OBJECTIVES: An increasingly important concern for clinicians who care for patients at the end of life is their spiritual well-being and sense of meaning and purpose in life. In response to the need for short-term interventions to address spiritual well-being, we developed Meaning Centered Group Psychotherapy (MCGP) to help patients with advanced cancer sustain or enhance a sense of meaning, peace and purpose in their lives, even as they approach the end of life. METHODS:Patients with advanced (stage III or IV) solid tumor cancers (N=90) were randomly assigned to either MCGP or a supportive group psychotherapy (SGP). Patients were assessed before and after completing the 8-week intervention, and again 2 months after completion. Outcome assessment included measures of spiritual well-being, meaning, hopelessness, desire for death, optimism/pessimism, anxiety, depression and overall quality of life. RESULTS:MCGP resulted in significantly greater improvements in spiritual well-being and a sense of meaning. Treatment gains were even more substantial (based on effect size estimates) at the second follow-up assessment. Improvements in anxiety and desire for death were also significant (and increased over time). There was no significant improvement on any of these variables for patients participating in SGP. CONCLUSIONS:MCGP appears to be a potentially beneficial intervention for patients' emotional and spiritual suffering at the end of life. Further research, with larger samples, is clearly needed to better understand the potential benefits of this novel intervention. (c) 2009 John Wiley & Sons, Ltd.
RCT Entities:
OBJECTIVES: An increasingly important concern for clinicians who care for patients at the end of life is their spiritual well-being and sense of meaning and purpose in life. In response to the need for short-term interventions to address spiritual well-being, we developed Meaning Centered Group Psychotherapy (MCGP) to help patients with advanced cancer sustain or enhance a sense of meaning, peace and purpose in their lives, even as they approach the end of life. METHODS:Patients with advanced (stage III or IV) solid tumor cancers (N=90) were randomly assigned to either MCGP or a supportive group psychotherapy (SGP). Patients were assessed before and after completing the 8-week intervention, and again 2 months after completion. Outcome assessment included measures of spiritual well-being, meaning, hopelessness, desire for death, optimism/pessimism, anxiety, depression and overall quality of life. RESULTS:MCGP resulted in significantly greater improvements in spiritual well-being and a sense of meaning. Treatment gains were even more substantial (based on effect size estimates) at the second follow-up assessment. Improvements in anxiety and desire for death were also significant (and increased over time). There was no significant improvement on any of these variables for patients participating in SGP. CONCLUSIONS:MCGP appears to be a potentially beneficial intervention for patients' emotional and spiritual suffering at the end of life. Further research, with larger samples, is clearly needed to better understand the potential benefits of this novel intervention. (c) 2009 John Wiley & Sons, Ltd.
Authors: W Breitbart; B Rosenfeld; H Pessin; M Kaim; J Funesti-Esch; M Galietta; C J Nelson; R Brescia Journal: JAMA Date: 2000-12-13 Impact factor: 56.272
Authors: David W Kissane; Sidney Bloch; Graeme C Smith; Patricia Miach; David M Clarke; Jillian Ikin; Anthony Love; Nadia Ranieri; Dean McKenzie Journal: Psychooncology Date: 2003-09 Impact factor: 3.894
Authors: Barry Rosenfeld; Rebecca Saracino; Kristen Tobias; Melissa Masterson; Hayley Pessin; Allison Applebaum; Robert Brescia; William Breitbart Journal: Palliat Med Date: 2016-07-21 Impact factor: 4.762
Authors: Lauren Z Davis; Michaela Cuneo; Premal H Thaker; Michael J Goodheart; David Bender; Susan K Lutgendorf Journal: Psychooncology Date: 2017-08-04 Impact factor: 3.894
Authors: Allison J Applebaum; Wendy G Lichtenthal; Hayley A Pessin; Julia N Radomski; N Simay Gökbayrak; Aviva M Katz; Barry Rosenfeld; William Breitbart Journal: Psychooncology Date: 2011-07-12 Impact factor: 3.894
Authors: Monika Brandstätter; Monika Kögler; Urs Baumann; Veronika Fensterer; Helmut Küchenhoff; Gian Domenico Borasio; Martin Johannes Fegg Journal: Support Care Cancer Date: 2014-01-03 Impact factor: 3.603
Authors: Lori P Montross; Emily A Meier; Kelly De Cervantes-Monteith; Vishal Vashistha; Scott A Irwin Journal: J Palliat Med Date: 2013-08-12 Impact factor: 2.947
Authors: William Breitbart; Hayley Pessin; Barry Rosenfeld; Allison J Applebaum; Wendy G Lichtenthal; Yuelin Li; Rebecca M Saracino; Allison M Marziliano; Melissa Masterson; Kristen Tobias; Natalie Fenn Journal: Cancer Date: 2018-05-14 Impact factor: 6.860
Authors: Lisa M Gudenkauf; Matthew M Clark; Paul J Novotny; Katherine M Piderman; Shawna L Ehlers; Christi A Patten; Lise Solberg Nes; Kathryn J Ruddy; Jeff A Sloan; Ping Yang Journal: Clin Lung Cancer Date: 2019-06-19 Impact factor: 4.785